REFERENCES
- Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73(6):1284-93.
- Clark C. Atopic eczema: clinical features and diagnosis. Clinical Pharmacist. 2010. 285-9.
- Torrelo A, Ortiz J, Alomar A, Ros S, Prieto M, Cuervo J. Atopic dermatitis: impact on quality of life and patients' attitudes toward its management. Eur J Dermatol. 2012;22(1):97-105.
- Zuberbier T, Orlow SJ, Paller AS, Taieb A, Allen R, Hernanz-Hermosa JM, et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):226-32.
- Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int. 2013;62(2):151-61.
- Bandier J, Johansen JD, Petersen LJ, Carlsen BC. Skin pH, atopic dermatitis, and filaggrin mutations. Dermatitis. 2014;25(3):127-9.
- Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839-42.
- Rawlings AV. Recent advances in skin 'barrier' research. J Pharm Pharmacol. 2010;62(6):671-7.
- Garidel P, Folting B, Schaller I, Kerth A. The microstructure of the stratum corneum lipid barrier: mid-infrared spectroscopic studies of hydrated ceramide:palmitic acid:cholesterol model systems. Biophys Chem. 2010;150(1-3):144-56.
- Miajlovic H, Fallon PG, Irvine AD, Foster TJ. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol. 2010;126(6):1184-90.e3.
- Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest. 2012;122(2):440-7.
- Bell DC, Brown SJ. Atopic eczema treatment now and in the future: Targeting the skin barrier and key immune mechanisms in human skin. World J Dermatol. 2017;6(3):42-51.
- Renert-Yuval Y, Guttman-Yassky E. Systemic therapies in atopic dermatitis: the pipeline. Clin Exp Dermatol. 2017;35(4):387-97.
- Wang B, McHugh BJ, Qureshi A, Campopiano DJ, Clarke DJ, Fitzgerald JR, et al. IL-1beta-induced protection of keratinocytes against staphylococcus aureus-secreted proteases is mediated by human beta-defensin 2. J Invest Dermatol. 2017;137(1):95-105.
- Raphael KL, Murphy RA, Shlipak MG, Satterfield S, Huston HK, Sebastian A, et al. Bicarbonate concentration, acid-base status, and mortality in the health, aging, and body composition study. Clin J Am Soc Nephrol. 2016;11(2):308-16.
- Luebberding S, Krueger N, Kerscher M. Skin physiology in men and women: in vivo evaluation of 300 people including TEWL, SC hydration, sebum content and skin surface pH. Int J Cosmet Sci. 2013;35(5):477-83.
- Prakash C, Bhargava P, Tiwari S, Majumdar B, Bhargava RK. Skin surface pH in acne vulgaris: insights from an observational study and review of the literature. J Cosmet Dermatol. 2017;10(7):33-9.
- Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129(8):1892-908.
- Ali SM, Yosipovitch G. Skin pH: from basic science to basic skin care. Acta Derm Venereol. 2013;93(3):261-7.
- Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850-9.
- Malik E, Dennison SR, Harris F, Phoenix DA. pH dependent antimicrobial peptides and proteins, their mechanisms of action and potential as therapeutic agents. Pharmaceuticals (Basel, Switzerland). 2016;9(4).
- Wesemann DR, Nagler CR. The microbiome, timing, and barrier function in the context of allergic disease. Immunity. 2016;44(4):728-38.
- Nakatsuji T, Chen TH, Narala S, Chun KA, Two AM, Yun T, et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med. 2017;9(378).
- Skotnicki S, Shulgan C. Beyond Soap: The Real Truth About What You Are Doing to Your Skin and How to Fix It for a Beautiful, Healthy Glow: Penguin Canada; 2018.
- Walters RM, Mao G, Gunn ET, Hornby S. Cleansing formulations that respect skin barrier integrity. J Dermatol Res Ther. 2012;2012:495917.
- Abbas S, Goldberg JW, Massaro M. Personal cleanser technology and clinical performance. Dermatol Ther. 2004;17 Suppl 1:35-42.
- Guenther L, Lynde CW, Andriessen A, Barankin B, Goldstein E, Skotnicki SP, et al. Pathway to dry skin prevention and treatment. J Cutan Med Surg. 2012;16(1):23-31.
- Lynde CW, Andriessen A. A cohort study on a ceramide-containing cleanser and moisturizer used for atopic dermatitis. Cutis. 2014;93(4):207-13.
- Vender RB, Andriessen A, Barankin B, Freiman A, Kyritsis D, Mistos LM, et al. Cohort using a ceramides containing cleanser and cream with salicylic acid for dry, flaking, and scaling skin conditions. J Drugs Dermatol. 2019;18(1):80-5.
- Simpson EL, Chalmers JR, Hanifin JM, Thomas KS, Cork MJ, McLean WH, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134(4):818-23.
- Horimukai K, Morita K, Narita M, Kondo M, Kitazawa H, Nozaki M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol. 2014;134(4):824-30.e6.
- Xu S, Immaneni S, Hazen GB, Silverberg JI, Paller AS, Lio PA. Cost-effectiveness of prophylactic moisturization for atopic dermatitis. JAMA Pediatrics. 2017;171(2):e163909.
- Danby SG, Brown K, Higgs-Bayliss T, Chittock J, Albenali L, Cork MJ. The effect of an emollient containing urea, ceramide np, and lactate on skin barrier structure and function in older people with dry skin. Skin Pharmacol Physiol. 2016;29(3):135-47.